Does LUMATEPERONE Cause Performance status decreased? 68 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 68 reports of Performance status decreased have been filed in association with LUMATEPERONE (CAPLYTA). This represents 1.4% of all adverse event reports for LUMATEPERONE.
68
Reports of Performance status decreased with LUMATEPERONE
1.4%
of all LUMATEPERONE reports
0
Deaths
2
Hospitalizations
How Dangerous Is Performance status decreased From LUMATEPERONE?
Of the 68 reports, 2 (2.9%) required hospitalization.
Is Performance status decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LUMATEPERONE. However, 68 reports have been filed with the FAERS database.
What Other Side Effects Does LUMATEPERONE Cause?
Dizziness (558)
Nausea (401)
Headache (358)
Somnolence (304)
Off label use (280)
Drug ineffective (241)
Mania (211)
Sedation (208)
Feeling abnormal (206)
Anxiety (183)
What Other Drugs Cause Performance status decreased?
BACLOFEN (156)
LENALIDOMIDE (118)
PACLITAXEL (112)
BEVACIZUMAB (103)
SODIUM OXYBATE (103)
CARBOPLATIN (100)
DEXAMETHASONE (80)
CAPECITABINE (75)
NIRAPARIB (75)
NIVOLUMAB (65)
Which LUMATEPERONE Alternatives Have Lower Performance status decreased Risk?
LUMATEPERONE vs LUMIGAN
LUMATEPERONE vs LUPRON DEPOT
LUMATEPERONE vs LUPRON DEPOT-PED
LUMATEPERONE vs LURASIDONE
LUMATEPERONE vs LURBINECTEDIN